Annual Operating Expenses
$192.95 M
+$28.79 M+17.54%
December 31, 2024
Summary
- As of March 13, 2025, AVIR annual total operating expenses is $192.95 million, with the most recent change of +$28.79 million (+17.54%) on December 31, 2024.
- During the last 3 years, AVIR annual operating expenses has fallen by -$20.04 million (-9.41%).
- AVIR annual operating expenses is now -9.41% below its all-time high of $212.99 million, reached on December 31, 2021.
Performance
AVIR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$39.03 M
+$1.82 M+4.90%
December 31, 2024
Summary
- As of March 13, 2025, AVIR quarterly total operating expenses is $39.03 million, with the most recent change of +$1.82 million (+4.90%) on December 31, 2024.
- Over the past year, AVIR quarterly operating expenses has dropped by -$7.55 million (-16.20%).
- AVIR quarterly operating expenses is now -45.03% below its all-time high of $71.00 million, reached on December 31, 2021.
Performance
AVIR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AVIR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.5% | -16.2% |
| 3 y3 years | -9.4% | -4.3% |
| 5 y5 years | +1220.8% | -4.3% |
AVIR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.4% | +47.7% | -45.0% | +139.7% |
| 5 y | 5-year | -9.4% | +1220.8% | -45.0% | +864.8% |
| alltime | all time | -9.4% | +1936.0% | -45.0% | +935.5% |
Atea Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $192.95 M(+17.5%) | $39.03 M(+4.9%) |
| Sep 2024 | - | $37.20 M(-20.7%) |
| Jun 2024 | - | $46.92 M(-32.8%) |
| Mar 2024 | - | $69.81 M(+49.9%) |
| Dec 2023 | $164.16 M(+25.7%) | $46.57 M(+14.2%) |
| Sep 2023 | - | $40.78 M(+15.8%) |
| Jun 2023 | - | $35.23 M(-15.2%) |
| Mar 2023 | - | $41.57 M(+4.2%) |
| Dec 2022 | $130.65 M | $39.90 M(+145.1%) |
| Sep 2022 | - | $16.28 M(-49.6%) |
| Jun 2022 | - | $32.30 M(-23.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $42.17 M(-40.6%) |
| Dec 2021 | $212.99 M(+257.0%) | $71.00 M(+29.2%) |
| Sep 2021 | - | $54.96 M(+6.3%) |
| Jun 2021 | - | $51.70 M(+46.3%) |
| Mar 2021 | - | $35.33 M(+26.2%) |
| Dec 2020 | $59.66 M(+308.4%) | $27.99 M(+58.7%) |
| Sep 2020 | - | $17.63 M(+76.2%) |
| Jun 2020 | - | $10.00 M(+147.3%) |
| Mar 2020 | - | $4.04 M(-14.8%) |
| Dec 2019 | $14.61 M(+54.1%) | $4.75 M(+26.0%) |
| Sep 2019 | - | $3.77 M |
| Dec 2018 | $9.48 M | - |
FAQ
- What is Atea Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual operating expenses year-on-year change?
- What is Atea Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly operating expenses year-on-year change?
What is Atea Pharmaceuticals annual total operating expenses?
The current annual operating expenses of AVIR is $192.95 M
What is the all time high annual operating expenses for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual total operating expenses is $212.99 M
What is Atea Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, AVIR annual total operating expenses has changed by +$28.79 M (+17.54%)
What is Atea Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of AVIR is $39.03 M
What is the all time high quarterly operating expenses for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly total operating expenses is $71.00 M
What is Atea Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, AVIR quarterly total operating expenses has changed by -$7.55 M (-16.20%)